LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
30.64
-0.17 (-0.55%)
At close: Oct 29, 2025, 4:00 PM EDT
30.64
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:10 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $820.34 million as of October 29, 2025. Its market cap has increased by 20.74% in one year.
Market Cap
820.34M
Enterprise Value
594.47M
1-Year Change
20.74%
Ranking
Category
Stock Price
$30.64
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $820.34M, an increase of 98.32%. That is a compound annual growth rate of 53.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 824.89M | 3.90% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 450.37B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |